• Fourteen patients with symptomatic and active Paget's disease of bone who had demonstrated resistance to parenteral synthetic salmon calcitonin, oral disodium etidronate, or both in combination were treated with parenteral synthetic human calcitonin. Eleven patients (79%) demonstrated clinical and chemical improvement for up to five years. Two patients received additional benefit with combined synthetic human calcitonin and etidronate disodium.
(Arch Intern Med 1987;147:1305-1308)
Altman RD, Collins-Yudiskas B. Synthetic Human Calcitonin in Refractory Paget's Disease of Bone. Arch Intern Med. 1987;147(7):1305–1308. doi:10.1001/archinte.1987.00370070119017
Customize your JAMA Network experience by selecting one or more topics from the list below.